News
One popular and affordable supplement that has shown some promise in helping with weight loss is berberine. In fact, some ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women ...
2d
Medindia on MSNZepbound Approved as First Drug for Sleep Apnea in Obese AdultsZepbound functions by targeting hormone receptors related to appetite regulation, specifically glucagon-like peptide-1 and ...
People enrolled in the military health care benefits program Tricare for Life no longer will be eligible for coverage of ...
Eli Lilly & Co. reports Q2 2025 results before the U.S. market opens on August 7. Analysts expect revenue of approximately ...
Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.
1d
Pharmaceutical Technology on MSNMounjaro and Zepbound fuel strong Q2 growth for Eli LillyEli Lilly reported $15.56bn in revenue, driven by its weight loss and diabetes drugs, intensifying pressure on rival Novo ...
Kym Whitley partners with Eli Lilly to share her transformative experience using Zepbound, an obesity management medication.
Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial ...
Eli Lilly raised its full-year profit and sales forecast on Thursday, betting on surging demand for its blockbuster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results